NR1H4 and hyperlipidemia: It has been reported that treatment with live P. distasonis can alter the bile acid profiles of mice, increasing the levels of LCA and UDCA, and in turn, reducing hyperlipidemia by activating the FXR pathway, and as a result, repairing gut barrier integrity (Wang et al., 2019).